Live Breaking News & Updates on Endeavor Biomedicines

Stay updated with breaking news from Endeavor biomedicines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ATS 2024: Building Real-World Data to Inform Clinical Practice and More Takeaways

Expert speakers at the American Thoracic Society (ATS) 2024 international conference share their favorite parts of the event and the key takeaways they will leave the conference with. ....

United-states , San-diego , California , Philadelphia , Pennsylvania , American , Chris-cielo , Julie-linton , Michael-arzt , Monica-kraft , Paula-frohna , Adam-benjafield

Endeavor's ENV-101 improves lung function in Phase IIa IPF trial

ENV-101 was found to be well-tolerated in the trial without any serious adverse events reported. ....

Endeavor-biomedicines , Trials-arena ,

Vicore and Endeavor's therapies show promise in treating IPF

Both drugs have the potential to offer a disease-modifying approach to the lung disease ....

Vicore-pharma , Endeavor-biomedicines ,

Endeavor links IPF drug to improved lung function in phase 2

The Hedgehog inhibitor data sent a sonic pulse through a sector currently dominated by drugs that only slow the decline of the disease. ....

Boehringer-ingelheim , Endeavor-biomedicines ,

Dr Paul Frohna Discusses Promising Results of Novel Hedgehog Inhibitor for IPF

Promising results from a phase 2 trial of ENV-101, a novel hedgehog inhibitor, showed improvement in lung function and reduction of fibrosis in patients with idiopathic pulmonary fibrosis, said Paul Frohna, MD, PhD, PharmD. ....

California , United-states , San-diego , American , Paul-frohna , American-thoracic-society , International-conference , Endeavor-biomedicines , Novel-hedgehog-inhibitor , Increases-lung-function , Reduces-lung-fibrosis , Results-from